The store will not work correctly when cookies are disabled.
ID: ALA2397459
Max Phase: Preclinical
Molecular Formula: C13H12ClN3O
Molecular Weight: 261.71
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: Cc1ccccc1CNC(=O)c1cnc(Cl)cn1
Standard InChI: InChI=1S/C13H12ClN3O/c1-9-4-2-3-5-10(9)6-17-13(18)11-7-16-12(14)8-15-11/h2-5,7-8H,6H2,1H3,(H,17,18)
Standard InChI Key: GZFZQXQYKOQIFJ-UHFFFAOYSA-N
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Properties
Molecular Weight: 261.71 | Molecular Weight (Monoisotopic): 261.0669 | AlogP: 2.37 | #Rotatable Bonds: 3 |
Polar Surface Area: 54.88 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.53 | CX Basic pKa: | CX LogP: 2.06 | CX LogD: 2.06 |
Aromatic Rings: 2 | Heavy Atoms: 18 | QED Weighted: 0.92 | Np Likeness Score: -1.73 |
References
1. Servusová B, Vobicková J, Paterová P, Kubíček V, Kuneš J, Doležal M, Doležal M, Zitko J.. (2013) Synthesis and antimycobacterial evaluation of N-substituted 5-chloropyrazine-2-carboxamides., 23 (12): [PMID:23659859] [10.1016/j.bmcl.2013.04.021] |